Evidence map›Paper›PMID 34162211›Full record

ArticleACS applied materials & interfaces2021

Scalable Purification of Plasmid DNA Nanoparticles by Tangential Flow Filtration for Systemic Delivery.

Heng-Wen Liu, Yizong Hu, Yong Ren, Hwanhee Nam, Jose Luis Santos, Shirley Ng, Like Gong, Mary Brummet, Christine A Carrington, Christopher G Ullman and 3 more

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Heng-Wen LiuDepartment of Materials Science and Engineering, Johns Hopkins University, Baltimore, Maryland 21218, United States.ORCID https://orcid.org/0000-0001-8179-919X
Yizong HuInstitute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland 21218, United States.ORCID https://orcid.org/0000-0003-3983-5104
Yong RenDepartment of Materials Science and Engineering, Johns Hopkins University, Baltimore, Maryland 21218, United States.
Hwanhee NamInstitute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland 21218, United States.
Jose Luis SantosDepartment of Materials Science and Engineering, Johns Hopkins University, Baltimore, Maryland 21218, United States.
Shirley NgDepartment of Materials Science and Engineering, Johns Hopkins University, Baltimore, Maryland 21218, United States.
Like GongDepartment of Materials Science and Engineering, Johns Hopkins University, Baltimore, Maryland 21218, United States.
Mary BrummetRussell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, United States.
Christine A CarringtonCancer Targeting Systems, Chesterford Research Park, Cambridge CB10 1XL, U.K.
Christopher G UllmanCancer Targeting Systems, Chesterford Research Park, Cambridge CB10 1XL, U.K.
Martin G PomperInstitute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland 21218, United States.ORCID https://orcid.org/0000-0001-6753-3010
Il MinnInstitute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland 21218, United States.ORCID https://orcid.org/0000-0002-7822-662X
Hai-Quan MaoDepartment of Materials Science and Engineering, Johns Hopkins University, Baltimore, Maryland 21218, United States.ORCID https://orcid.org/0000-0002-4262-9988

Funding

TRANSGENIC MODELS FOR PROSTATE CANCER AND AUTOIMMUNITYP50CA058236 · NCI · JOHNS HOPKINS UNIVERSITY · PI DENMEADE, SAMUEL R · 1992 to 2020
$43.9M
Training/Dissemination-Resource for Molecular Imaging Agents in Precision MedicineP41EB024495 · NIBIB · UT SOUTHWESTERN MEDICAL CENTER · PI MARTIN G POMPER · 2017 to 2026
$11.8M
Shape Control and Transport Properties of DNA-Copolymer MicellesR01EB018358 · NIBIB · JOHNS HOPKINS UNIVERSITY · PI LUIJTEN, ERIK, MAO, HAI-QUAN · 2015 to 2018
$2.1M
NCI NIH HHS P50 CA058236NIBIB NIH HHS P41 EB024495NIBIB NIH HHS R01 EB018358
6 · The paper itself

Abstract

Plasmid DNA (pDNA) nanoparticles synthesized by complexation with linear polyethylenimine (lPEI) are one of the most effective non-viral gene delivery vehicles. However, the lack of scalable and reproducible production methods and the high toxicity have hindered their clinical translation. Previously, we have developed a scalable flash nanocomplexation (FNC) technique to formulate pDNA/lPEI nanoparticles using a continuous flow process. Here, we report a tangential flow filtration (TFF)-based scalable purification method to reduce the uncomplexed lPEI concentration in the nanoparticle formulation and improve its biocompatibility. The optimized procedures achieved a 60% reduction of the uncomplexed lPEI with preservation of the nanoparticle size and morphology. Both

Indexed as

AnimalsDNAFemaleFiltrationGene Transfer TechniquesHumansMiceMice, Inbred BALB CNanoparticlesPC-3 CellsPlasmidsPolyethyleneimineDNAPolyethyleneiminebiocompatibilityDNA nanoparticlesgene deliverylinear PEItangential flow filtration

Identifiers

PMID34162211
PMCPMC9701136

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.